tiprankstipranks
Advertisement
Advertisement

Amrize price target raised to $66 from $59 at Wells Fargo

Wells Fargo analyst Timna Tanners raised the firm’s price target on Amrize (AMRZ) to $66 from $59 and keeps an Overweight rating on the shares. The firm notes Q4 featured an above-consensus 2026 guide, plus a 4.5% shareholder yield from the proposed buyback and dividend, and signs of a bottom in residential-exposed Building Envelope. The delivery of multiple catalysts supports Wells’ Overweight stance.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1